Related Experiment Video

Updated: May 17, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Proliferative and antiapoptotic signaling stimulated by nuclear-localized PDK1 results in oncogenesis

Chintan K Kikani1, Erik V Verona, Jiyoon Ryu

  • 1Department of Biochemistry, University of Texas Health Science Center, San Antonio, TX 78229, USA.

Science Signaling
|November 8, 2012
PubMed

Insights

Nuclear phosphoinositide-dependent protein kinase 1 (PDK1) drives cancer growth by suppressing cell cycle inhibitors and promoting survival pathways. Nuclear PDK1 correlates with high-risk tumors, suggesting its role in oncogenic transformation and progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Enhanced phosphoinositide 3-kinase (PI3K) activity is common in human tumors, promoting cell proliferation and survival.
  • Phosphoinositide-dependent protein kinase 1 (PDK1) is activated by PI3K and phosphorylates Akt, a key signaling molecule.
  • Previous studies showed increased nuclear PDK1 in cells with enhanced PI3K activity.

Purpose of the Study:

  • To investigate the role of nuclear PDK1 in cancer cell proliferation and survival.
  • To determine the mechanisms by which nuclear PDK1 influences oncogenic transformation.
  • To correlate PDK1 localization with tumor risk in human prostate cancer.

Main Methods:

  • Cell culture experiments to assess proliferation and survival.
  • Western blotting and gene expression analysis to study signaling pathways.
  • Xenograft mouse models to evaluate tumor formation.
  • Immunohistochemistry to analyze PDK1 localization in human prostate tumors.

Main Results:

  • Nuclear PDK1 suppressed FOXO3A-dependent transcription of p27Kip1, an inhibitor of cell cycle progression.
  • Nuclear PDK1 inhibited c-Jun amino-terminal kinase activation, enhancing cell survival.
  • Cells with nuclear PDK1 exhibited anchorage-independent growth and formed solid tumors in mice.
  • Nuclear PDK1 localization in human prostate tumors correlated with high-risk disease, unlike cytoplasmic localization.

Conclusions:

  • Nuclear translocation of PDK1 plays a significant role in oncogenic cellular transformation.
  • Nuclear PDK1 promotes tumor progression by affecting cell cycle and survival pathways.
  • PDK1 localization serves as a potential biomarker for prostate cancer risk and progression.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...